Radiation therapy quality assurance firm ScandiDos said it expects to launch its Delta4 Discover in vivo dosimetry system in the U.S. within the next few months.
Delta4 Discover will offer tools for calculating the delivered dose during radiation therapy procedures, according to the firm. ScandiDos plans to release Delta4 Discover after it completes beta testing and receives U.S. Food and Drug Administration (FDA) clearance.
